Testing a new drug's safety in healthy volunteers
Part of Cancer clinical trials.
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in generally good health, as checked by medical history, physical exam, and lab tests.
- You must be of exclusive Japanese or Chinese descent, with all four biological grandparents born in Japan, China, Hong Kong, Macau, or Taiwan.
- Your body mass index (BMI) must be between 18.5 and 30.
- If you are assigned female at birth, you must not be able to become pregnant or be not breastfeeding. If assigned male at birth, you must use effective birth control during the study.
- You must be willing to have repeated lumbar punctures (spinal taps).
- You cannot have certain heart risks, hepatitis B or C, or be allergic to the study drug or similar antibodies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called LY4088044 in healthy people to see how it affects the body. It helps doctors learn about the drug's safety before testing it in patients with a disease.
This study tests a new medicine called LY4226695 in healthy people to see how safe it is and how the body handles it. It is an early-stage trial, and participating may help develop a new treatment option.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
This is an early-stage study testing a new experimental medicine called LY4302814 in healthy volunteers to see if it is safe and how the body processes it. By enrolling healthy people first, researchers can understand the drug's basic safety profile before testing it in patients with medical conditions.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This study tests an investigational medication in healthy volunteers and people with Alzheimer's disease. It aims to understand how the drug works and its safety.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.